These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 30061271)
1. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer. Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271 [TBL] [Abstract][Full Text] [Related]
2. Relationship Between FDG Uptake and the Platelet/lymphocyte Ratio in Patients With Breast Invasive Ductal Cancer. Fujii T; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Shirabe K In Vivo; 2020; 34(3):1365-1369. PubMed ID: 32354932 [TBL] [Abstract][Full Text] [Related]
3. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer. Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383 [TBL] [Abstract][Full Text] [Related]
4. FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer. Hirakata T; Fujii T; Kurozumi S; Katayama A; Honda C; Yanai K; Tokuda S; Nakazawa Y; Obayashi S; Yajima R; Kaira K; Oyama T; Shirabe K Breast Cancer Res Treat; 2020 Jun; 181(2):331-338. PubMed ID: 32253685 [TBL] [Abstract][Full Text] [Related]
5. Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer. Jo JE; Kim JY; Lee SH; Kim S; Kang T Acta Radiol; 2015 Dec; 56(12):1463-70. PubMed ID: 25406431 [TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors. Karan B; Pourbagher A; Torun N J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of SUV Diao W; Tian F; Jia Z Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer. Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of primary tumor SUV Yoo J; Yoon HJ; Kim BS Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection. Lee JW; Na JO; Kang DY; Lee SY; Lee SM Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma]. Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341 [TBL] [Abstract][Full Text] [Related]
13. Increased Prostate Cancer Glucose Metabolism Detected by Lavallée E; Bergeron M; Buteau FA; Blouin AC; Duchesnay N; Dujardin T; Tiguert R; Lacombe L; Fradet V; Makao-Nguile M; Fradet Y; Beauregard JM; Pouliot F Eur Urol Focus; 2019 Nov; 5(6):998-1006. PubMed ID: 29609897 [TBL] [Abstract][Full Text] [Related]
14. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma. Jung NY; Kim SH; Choi BB; Kim SH; Sung MS World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934 [TBL] [Abstract][Full Text] [Related]
19. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis. Jung NY; Kim SH; Kang BJ; Park SY; Chung MH Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608 [TBL] [Abstract][Full Text] [Related]
20. Relationship between reticuloendothelial systems' FDG uptake level and clinicopathological features in patient with invasive ductal breast cancer. Şahin E; Elboğa U Radiol Med; 2017 Oct; 122(10):785-792. PubMed ID: 28597239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]